Head-to-head for women
Oak vs Gala Health
Oak and Gala Health both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.
Oak
Ranked #14 for women · Grade B
Luna Fit
Best for: Women who want the lowest published price for tirzepatide without a membership fee, and who would rather buy a package than manage a recurring plan.
Visit OakGala Health
Higher scoreRanked #3 for women · Grade B+
Luna Fit
Best for: Women who want a low-cost compounded tirzepatide on-ramp nationwide, value having a brand-Ozempic escape hatch, and appreciate a provider that also treats the hormone side through its HRT and menopause line.
Visit Gala HealthThe verdict for women
Gala Health edges out Oak on the Luna Fit Score, 87 to 83 (B+ vs B). Women who want a low-cost compounded tirzepatide on-ramp nationwide, value having a brand-Ozempic escape hatch, and appreciate a provider that also treats the hormone side through its HRT and menopause line.
Oak is still a genuine option — the cheapest published entry point for both molecules on this board, sold as one-off packages rather than a subscription — and offered in Spanish as well as English. Weigh the six women's-health factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | Oak | Gala Health |
|---|---|---|
| Luna Fit Score | 83/100 · B | 87/100 · B+ |
| Overall rank | #14 | #3 |
| Semaglutide | From $119/mo | $1,299/mo |
| Tirzepatide | From $185/mo | $179/mo |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Injection only |
Luna Fit
Oak
Ranked #14 · Grade B
What we like
- Lowest published prices on this board for both molecules — semaglutide from $119/mo, tirzepatide from $185/mo
- One price across all dosages, so titration does not raise the cost
- No membership or subscription fee, and free shipping
The caveats
- Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are
- No brand-name path and no oral or sublingual route
- Same-day approval with no video call required — fast, but it means little clinical contact before a prescription
Luna Fit
Gala Health
Ranked #3 · Grade B+
What we like
- Very low compounded entry — tirzepatide from $179, microdose from $149, three-month plans from $199
- Available across all 50 states — a rare full-nationwide footprint
- Offers a brand path (Ozempic) alongside compounded, so you aren't locked to one route
The caveats
- Compounded medication is not FDA-approved the way brand Ozempic or Zepbound are
- Brand-name access is very expensive — Ozempic runs about $1,299/mo
- No oral or sublingual route yet — injections only for the needle-averse
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Luna Fit Score; affiliate partners carry a capped 6-point edge in list order, never in the score itself. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing Oak and Gala Health against other providers we review for women.
- Oak vs CoreAge Rx
- Oak vs Enhance MD
- Oak vs yourEra
- Gala Health vs Sesame Care
- Gala Health vs HealthRX
- Gala Health vs Strut Health
Or browse the full comparison hub.